Epitope specificity of HLA class I alloantibodies: II. Stability of cross-reactive group antibody patterns over extended time periods.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Transplantation

• Publication date

  1997-03-27

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1097/00007890-199703270-00015PMID 9089230
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cross-reactive HL-A antibodies. Separation of multiple HL-A antibody specificities by platelet adsorption and acid elution.

  2008cited by this paper
• Detection of alloantibodies using a sensitive antiglobulin microcytotoxicity test: identification of low levels of pre-formed antibodies in accelerated allograft rejection.

  2008cited by this paper
• Nomenclature for factors of the HLA system, 1995.

  1995cited by this paper
• A rapid flow cytometry assay for HLA antibody detection using a pooled cell panel covering 14 serological crossreacting groups.

  1995cited by this paper
• Epitope specificity of HLA class I alloantibodies. I. Frequency analysis of antibodies to private versus public specificities in potential transplant recipients.

  1994cited by this paper
• Computer algorithm that predicts both acceptable and unacceptable private and public HLA class I antigens in highly sensitized patients.

  1993cited by this paper
• Flow cytometry PRA, a new test that is highly correlated with graft survival

  1992cited by this paper
• The flow cytometric crossmatch and early renal transplant loss.

  1990cited by this paper
• Improved graft survival for flow cytometry and antihuman globulin crossmatch-negative retransplant recipients.

  1990cited by this paper
• Epitope map of the HLA-B7 CREG using affinity-purified human alloantibody probes.

  1990cited by this paper
• Topographic map of the HLA-A2 CREG epitopes using human alloantibody probes.

  1990cited by this paper
• Public epitopes and the antigenic structure of the HLA molecules.

  1987cited by this paper
• Effect of antiidiotypic antibodies to HLA on graft survival in renal-allograft recipients.

  1987cited by this paper
• Further studies on the epitopes of HLA-B7 defined by murine monoclonal antibodies.

  1986cited by this paper
• The primary structure of HLA-A32 suggests a region involved in formation of the Bw4/Bw6 epitopes.

  1986cited by this paper
• Prediction of crossmatch outcome in highly sensitized dialysis patients based on the identification of serum HLA antibodies.

  1986cited by this paper
• The atomic mobility component of protein antigenicity.

  1985cited by this paper
• Assessment of the risk for broad sensitization by blood transfusions.

  1984cited by this paper
• New approaches to donor crossmatching and successful transplantation of highly sensitized patients.

  1983cited by this paper
• COMPARATIVE EFFECTS OF PREGNANCY, TRANSFUSION, AND PRIOR GRAFT REJECTION ON SENSITIZATION AND RENAL TRANSPLANT RESULTS

  1982cited by this paper
• Functional significance of flexibility in proteins

  1982cited by this paper
• Development of anti-HLA antibodies following renal transplantation--their characteristics and natural history.

  1982cited by this paper
• ANTIGENIC SPECIFICITY OF ANTIBODY REACTIVE IN THE ANTIGLOBULIN‐AUGMENTED LYMPHOCYTOTOXICITY TEST

  1982cited by this paper
• HLA serological cross-reactivity: HLA-B15 has two public antigens.

  1980cited by this paper
• Public antigenic determinant on a family of HLA-B molecules.

  1979cited by this paper
• Microdroplet testing for HLA-A, -B, -C, and -D antigens. The Phillip Levine Award Lecture.

  1978cited by this paper
• A comparison of the antiglobulin versus extended incubation time crossmatch: results in 223 renal transplants.

  1977cited by this paper
• Simultaneous detection of two cell populations by two-colour fluorescence and application to the recognition of B-cell determinants

  1976cited by this paper
• HLA‐B specificities and w4, w6 specificities are on the same polypeptide

  1976cited by this paper
• Procurement and Identification of HL‐A Lymphocytotoxic Antibodies in Sera of Nonpregnant, Multiparous Blood Donors

  1974cited by this paper

• Microfluidic antibody affinity profiling of alloantibody-HLA interactions in human serum.

  2023cites this paper
• Microfluidic Antibody Affinity Profiling for In-Solution Characterisation of Alloantibody - HLA Interactions in Human Serum

  2020cites this paper
• Association of HLA Antigen Mismatch With Risk of Developing Skin Cancer After Solid-Organ Transplant

  2019cites this paper
• Measuring alloantibodies: a matter of quantity and quality

  2019cites this paper
• Bovine Neonatal Pancytopenia-Associated Alloantibodies Recognize Individual Bovine Leukocyte Antigen 1 Alleles

  2018cites this paper
• Are We Ready for Epitope-Based HLA Matching in Clinical Organ Transplantation?

  2017cites this paper
• Immunogenicity of Decidual Stromal Cells in an Epidermolysis Bullosa Patient and in Allogeneic Hematopoietic Stem Cell Transplantation Patients

  2015cites this paper
• Determination of an unrelated donor pool size for human leukocyte antigen-matched platelets in Brazil

  2015cites this paper
• Identification of patients with increased immunological risk among potential kidney recipients in the Polish population.

  2014cites this paper
• Flow Cytometric Human Leukocyte Antigen-B27 Typing with Stored Samples for Batch Testing

  2013cites this paper
• Evaluation of Flow Cytometric Crossmatch Results in Comparison with Donor-specific Antibodies Detected by Luminex-PRA Tests in Organ Transplantation Patients

  2012cites this paper
• Human Leukocyte Antigen

  2011cites this paper
• Artificial neural network weights of residues for the serological specificities of HLA

  2011cites this paper
• Antibody-reactive epitope determination with HLAMatchmaker and its clinical applications.

  2011cites this paper
• [Changes in the structure and clinical significance of the positive results of pretransfusion testing during the switching from tube test agglutination to gel microcolumn technique].

  2010cites this paper
• The HLA System and Histocompatibility Testing for Organ Transplantation

  2009cites this paper
• Recommendations of the ISBT Working Party on Granulocyte Immunobiology for leucocyte antibody screening in the investigation and prevention of antibody‐mediated transfusion‐related acute lung injury

  2009cites this paper
• Solid phase testing in the HLA laboratory: implications for organ allocation

  2008cites this paper
• [Experience on identification of cross-reactive group specificity performed by anti-human globulin panel reactive antibody tests].

  2008influential citation
• [Development of a web-based program for the identification of human leukocyte antigen antibody specificities].

  2007influential citation
• Public Epitope Specificity of HLA Class I Antibodies Induced by a Failed Kidney Transplant: Alloantibody Characterization by Flow Cytometric Techniques

  2006cites this paper
• Influence of mismatching of HLA cross-reactive groups on cadaveric kidney transplantation.

  2005cites this paper
• Untersuchung von nierentransplantierten Patienten unter Berücksichtigung der HLA-Kompatibilität und der Dynamik der HLA-Antikörperbildung

  2005influential citation
• HLA class I donor-specific triplet antibodies detected after renal transplantation.

  2004cites this paper
• No Impact of Cross‐Reactive Group Human Leucocyte Antigen Class I Matching on Long‐Term Kidney Graft Survival

  2003cites this paper
• Prospective trial of a predictive algorithm to transplant cadaver kidneys into highly sensitized patients1

  2002cites this paper
• Long-term kidney graft survival across a positive historic but negative current sensitized cross-match.

  2002cites this paper
• Comparison of different techniques for detection of anti-HLA antibodies in sera from patients awaiting kidney transplantation.

  2002cites this paper
• HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. I. Description of the algorithm.

  2002cites this paper
• Sensitisation to Swine Leukocyte Antigens in Patients with Broadly Reactive HLA Specific Antibodies

  2002cites this paper
• HLAMMATCHMAKER: a molecularly based donor selection algorithm for highly alloimmunized patients.

  2001cites this paper
• The role of HLA class I and class II antibodies in renal transplantation.

  2001cites this paper
• Characterization of HLA class I specific antibodies by ELISA using solubilized antigen targets: I. Evaluation of the GTI QuikID assay and analysis of antibody patterns.

  2001cites this paper
• The role of HLA class I and class II antibodies in renal transplantation

  2001cites this paper
• EFFECT OF Bw4 AND Bw6 EPITOPE MISMATCHES ON ANTIBODY PRODUCTION, ACUTE AND CHRONIC REJECTION, AND GRAFT SURVIVAL IN RENAL ALLOGRAFTS

  2001cites this paper
• In vitro CTL precursor frequencies do not reflect a beneficial effect of cross-reactive group (CREG) matching.

  2000cites this paper
• Cross-reactive group matching does not lead to a better allocation and survival of donor kidneys.

  2000cites this paper
• Epitope analysis of HLA class I donor specific antibodies in sensitized renal transplant recipients.

  2000cites this paper
• The application of flow cytometry to histocompatibility testing.

  2000cites this paper
• A limited number of HLA epitopes are recognized from HLA class I-specific antibodies detected in the serum of sensitized patients.

  2000cites this paper
• Acute Renal Failure after Large Doses of Intravenous Immune Globulin

  1999cites this paper
• Anti-HLA antibodies interfere in the detection of soluble HLA class I molecules.

  1999cites this paper
• Development of anti-HLA-antibodies against intra-CREG-mismatches in renal transplant recipients.

  1999cites this paper
• Histocompatibility Testing in Organ Transplantation

  1999cites this paper
• The humoral immune response against an HLA class I allodeterminant correlates with the HLA-DR phenotype of the responder.

  1999cites this paper
• Maximizing the benefits of HLA matching for renal transplantation: alleles, specificities, cregs, epitopes, or residues.

  1999cites this paper
• Differences in anti-CREG antibody formation between transplanted and nontransplanted renal patients.

  1999cites this paper
• Plasmapheresis during cardiopulmonary bypass: a proposed treatment for presensitized cardiac transplantation patients.

  1999cites this paper
• Evaluation of HLA matching for CREG antigens in Europe.

  1999cites this paper
• Antibodies to private and public HLA class I epitopes in platelet recipients

  1999cites this paper
• The immunologically sensitised renal transplant recipient: the impact of advances in technology on organ allocation and transplant outcome

  1999cites this paper
• Evaluation of HLA-class I alloantibodies using PRA-STAT and complement-dependent cytotoxicity techniques.

  1998cites this paper
• Assignment of HLA-antigens in CREGs facilitates the detection of acceptable mismatches in highly sensitized patients.

  1998cites this paper
• Is histocompatibility testing needed for composite tissue transplantation?

  1998cites this paper
• Donor-Specific Triplet Antibodies Detected After Renal ransplantation

  year unknowncites this paper